Direxion Daily LLY Bull 2X Shares (ELIL) seeks to provide 200% of the daily performance of Eli Lilly and Company (LLY) stock. This single-stock leveraged ETF amplifies the daily price movements of the pharmaceutical giant known for diabetes treatments, weight-loss drugs, and Alzheimer's therapies.
How It Works
ELIL uses derivatives including swaps and futures contracts to achieve twice the daily return of LLY stock through mathematical leverage rather than borrowing. The fund rebalances daily at market close to maintain its 2x exposure target, resetting the leverage ratio each trading day. As a single-stock ETF, it holds derivatives tied exclusively to Eli Lilly's share price performance, with no diversification across other pharmaceutical companies or sectors.
Key Features
- Provides 2x leveraged exposure to Eli Lilly, capitalizing on the company's leadership in diabetes and obesity drug markets
- Daily rebalancing maintains precise 2x leverage ratio, ensuring consistent amplification of LLY's daily price movements
- Focuses on single pharmaceutical stock with significant exposure to blockbuster drugs like Mounjaro and Zepbound
Risks
- This ETF can lose value rapidly due to daily compounding effects—if LLY drops 10% then rises 10%, the fund does not return to break-even
- Single-stock concentration means 100% exposure to Eli Lilly's specific risks including drug trial failures, regulatory setbacks, and patent expirations
- Pharmaceutical sector volatility can cause extreme price swings, with potential for 40-60% daily moves during earnings or FDA announcements
Who Should Own This
Best suited for experienced traders with high risk tolerance seeking short-term (hours to days) tactical exposure to Eli Lilly's price movements. Requires active monitoring and should represent less than 5% of total portfolio. Unsuitable for buy-and-hold investors due to daily reset compounding effects that erode returns over time.